Hipgnosis Song Management Limited

Hipgnosis Songs Fund Limited, based in the UK, specializes in music rights investment and management, acquiring, protecting, and enhancing music rights for artists and songwriters worldwide. Founded in 2018 in London, UK, Hipgnosis Songs Fund Limited is focused on music rights investment and management. The company has engaged in 4 notable deals, with its most recent being Public to Private funding of USD 1,572. 00 mn from Blackstone Group.

The firm was co-founded by Merck Mercuriadis, who has a history in the music industry, aiming to capitalize on the value of music rights. Hipgnosis Songs Fund Limited manages an extensive catalog of over 45,000 songs and recordings, ensuring that songwriters and artists receive appropriate royalties and protection from unauthorized use. The company’s core offerings include music rights management, allowing artists to focus on their creative pursuits while maximizing the commercial potential of their work. Their client base spans songwriters, recording artists, and music publishers, primarily in the US, UK, and Canada.

In the most recent fiscal year 2023, Hipgnosis Songs Fund Limited reported revenue of USD 13. 19 mn, with an EBITDA of USD -6. 20 mn, reflecting its active role in music rights management and investment. With the acquisition by Concord Chorus expected to finalize on April 17, 2024, Hipgnosis Songs Fund Limited aims to leverage this transaction to expand its scale and enhance operational capabilities.

This acquisition, valued at USD 1,402. 70 mn, will support the company's growth strategy, allowing for potential expansion into new markets, strengthening its position in existing territories, and maximizing business operations.